By Geoff Colvin, senior editor-at-large
FORTUNE -- Until now, the role of chewy cookies in A.G. Lafley's standout success as Procter & Gamble's CEO from 2000 to 2009 has not been disclosed. Yet if not for the Duncan Hines packaged chocolate chip cookie, Lafley's life story, the wealth of P&G shareholders, and even our understanding of corporate strategy might have been very different.
P&G shook the cookie trade in the mid-'80s by introducing products with a crispy outside and a chewy inside. Major competitors -- Nabisco, Keebler, Frito-Lay -- immediately flooded the market with copies and crushed P&G's (PG) early dominance of the category. Whether those competitors knew they were violating P&G's chewy-cookie technology patents has never been established, but they eventually paid $125 million, a record at the time, to settle a P&G patent-infringement lawsuit.
Victory for P&G? Not exactly. Chewy cookies were not the next big thing. P&G's cookie business crumbled (for many reasons). The company wrote down its value and eventually sold it, while those competitors are still giants in the industry.
MORE: Can Procter & Gamble CEO Bob McDonald hang on?
P&G clearly needed help with competitive strategy. "John Smale [CEO at the time] got so frustrated that he called in Michael Porter," Lafley recalls. Porter was, and is, a Harvard Business School professor and the world's top expert on the subject. Smale hired him to teach it to P&G executives. And Lafley, then a 39-year-old manager in laundry products, was in Porter's first class.
Lafley learned from the master what is still the most rigorous and deeply grounded approach to corporate strategy, and he never forgot it. He also got to know Porter's consulting firm, Monitor Group, and one of its stars, Roger Martin, and never forgot him either. They formed a business relationship that continued through Lafley's time as CEO, even after Martin left Monitor to become dean of the University of Toronto's Rotman School of Business.
The Porter-Monitor approach to strategy "didn't take" at P&G, Lafley says, but it took with him. He brought it back 14 years later when he was suddenly made CEO after Durk Jager got fired, with the company's stock in free fall. Lafley's groundbreaking redirection of P&G's strategy was critical to the company's success during his tenure; market cap doubled in a decade during which the S&P declined. More
As dean of the world's most powerful and influential business school, the 50-year-old Nohria has unflinchingly led the school into a new brave era.
By John A. Byrne
(Poets&Quants) -- It was four days before last year's graduation at the Harvard Business School when Dean Nitin Nohria received the anguished phone call at his home on a Sunday afternoon. Two distressed MBA students had some rather tragic news: an MBA classmate MORE
Jan 7, 2013 11:34 AM ET
How companies can get America's edge back while advancing their own interests.
By Michael Porter and Jan Rivkin
FORTUNE - America's feeble economy reminds us every day that our global competitiveness is in trouble. Whose fault is that? As usual in today's political environment, most opinions are extreme. One camp holds that national competitiveness is the responsibility of policymakers, not business leaders, who need to focus on running their companies. MORE
Oct 15, 2012 5:00 AM ET
He has influenced more executives - and more nations - than any other business professor on earth. Now, at 65, he and an all-star team aim to rescue the U.S. economy.
By Geoff Colvin, senior editor-at-large
FORTUNE -- Right this minute, in offices around the world, business-people are holding high-level meetings to talk about strategy. They're trying to figure out if they can really achieve the lowest costs, or if they MORE
Oct 15, 2012 5:00 AM ET
Is there any hope for America's political process? Not much, was the answer from the group of Harvard Business School faculty gathered in Washington last week. By Anne VanderMey
Jun 25, 2012 9:22 AM ET| Bernanke's advice for college grads | ||
| The Winklevoss twins are Bitcoin bulls | ||
| Dirty medicine | ||
| Bloomberg's lazy Apple bias | ||
| Signs of new housing bubble in several areas |